Dyno Therapeutics
Designs AI-powered AAV vectors for targeted gene therapy delivery.
a16z — Backed by a16z H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.aibiotech
Company facts
- Founded
- 2018
- Employees
- 96
- Headquarters
- United States
- Type
- Private
- Funding
- Series A · $100M · 2021